These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38934027)

  • 1. The effect of pharmacist-led medication therapy management in the multidisciplinary care of acute kidney injury survivors.
    Wang T; Kang HC; Wu CC; Wu TL; Huang CF; Wu VC
    Kidney Res Clin Pract; 2024 Jun; ():. PubMed ID: 38934027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist-provider collaborative visits after hospital discharge in a comprehensive acute kidney injury survivor model.
    Herges JR; May HP; Meade L; Anderson B; Tinaglia AG; Schreier DJ; Kashani KB; Kattah A; McCoy RG; Rule AD; Mara KC; Barreto EF;
    J Am Pharm Assoc (2003); 2023; 63(3):909-914. PubMed ID: 36702735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Pharmacist-Led Medication Therapy Management on Medication Adherence and Use of Non-Steroidal Anti-Inflammatory Drug in Patients with Pre-End Stage Renal Disease.
    Wang T; Kang HC; Chen CC; Lai TS; Huang CF; Wu CC
    Patient Prefer Adherence; 2024; 18():267-274. PubMed ID: 38327729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective evaluation of medication appropriateness and clinical pharmacist drug therapy recommendations for home-based primary care veterans.
    Davis RG; Hepfinger CA; Sauer KA; Wilhardt MS
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):40-7. PubMed ID: 17608246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the clinical pharmacist in the prevention of drug-induced acute kidney injury in the intensive care unit.
    Polat EC; Koc A; Demirkan K
    J Clin Pharm Ther; 2022 Dec; 47(12):2287-2294. PubMed ID: 36394173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Multidisciplinary Post-Acute Kidney Injury Clinic on Awareness and Knowledge in Acute Kidney Injury Survivors.
    Thanapongsatorn P; Krisem M; Kaewnan K; Bumrungpet T; Srisawat N
    Blood Purif; 2024; 53(4):268-278. PubMed ID: 37989123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist-led medication therapy management of diabetes club patients at a primary healthcare clinic in Cape Town, South Africa: A retrospective and prospective audit.
    Sonday F; Bheekie A; Van Huyssteen M
    S Afr Med J; 2022 May; 112(6):437-445. PubMed ID: 36217874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention.
    Smith A; Hansen J; Colvard M
    J Subst Abuse Treat; 2021 Nov; 130():108440. PubMed ID: 34118708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate.
    Arnold ME; Buys L; Fullas F
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S36-42. PubMed ID: 25991594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review.
    Stuijt CC; Franssen EJ; Egberts AC; Hudson SA
    Drugs Aging; 2008; 25(11):947-54. PubMed ID: 18947262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
    Perera PN; Guy MC; Sweaney AM; Boesen KP
    J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pharmacist care on medication adherence and cardiovascular outcomes among patients post-acute coronary syndrome: A systematic review.
    El Hajj MS; Jaam MJ; Awaisu A
    Res Social Adm Pharm; 2018 Jun; 14(6):507-520. PubMed ID: 28641999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Standardized Warfarin Treatment Protocol on Anticoagulant Effect: Comparison of a Warfarin Medication Therapy Adherence Clinic with Usual Medical Care.
    Aidit S; Soh YC; Yap CS; Khan TM; Neoh CF; Shaharuddin S; Kassab YW; Patel RP; Ming LC
    Front Pharmacol; 2017; 8():637. PubMed ID: 29170637
    [No Abstract]   [Full Text] [Related]  

  • 15. Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action): Reduction of Nephrotoxic Medication-Associated Acute Kidney Injury in the Neonatal Intensive Care Unit.
    Stoops C; Stone S; Evans E; Dill L; Henderson T; Griffin R; Goldstein SL; Coghill C; Askenazi DJ
    J Pediatr; 2019 Dec; 215():223-228.e6. PubMed ID: 31761141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home medication management review in outpatients with chronic diseases in Jordan: a randomized control trial.
    Basheti IA; Al-Qudah RA; Obeidat NM; Bulatova NR
    Int J Clin Pharm; 2016 Apr; 38(2):404-13. PubMed ID: 26960406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL; Jones MK; Ritter M
    J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of pharmacist interventions in an ambulatory palliative care practice.
    Ma JD; Tran V; Chan C; Mitchell WM; Atayee RS
    J Oncol Pharm Pract; 2016 Dec; 22(6):757-765. PubMed ID: 26428283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of pharmacist intervention model for chronic kidney disease patients; a prospective comparative study.
    Khokhar A; Khan YH; Mallhi TH; Khan HM; Alotaibi NH; Alzarea AI; Bokharee N
    Int J Clin Pharm; 2020 Apr; 42(2):625-634. PubMed ID: 32026352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.